Legato Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Legato Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$321K	Buy	+15,960	New	+$257K	0.03%	619
2024 Q3	–	Sell	-23,674	Closed	-$279K	–	602
2024 Q2	$279K	Hold	23,674	–	–	0.04%	495
2024 Q1	$281K	Buy	+23,674	New	+$316K	0.03%	514
2021 Q3	–	Sell	-12,903	Closed	-$309K	–	262
2021 Q2	$309K	Buy	+12,903	New	+$338K	0.04%	321

Other funds holding KALV

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legato Capital Management's KALV Position: Q1 2026 in Review

Legato Capital Management opened a new position in KalVista Pharmaceuticals (KALV) in Q1 2026: 15,960 shares worth $321K. The stake represents 0.03% of the portfolio and ranks #619 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in KALV as recently as Q2 2024.

Legato Capital Management first reported a position in KALV in Q2 2021 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

Legato Capital Management held 15,960 shares of KalVista Pharmaceuticals worth $321K as of Q1 2026.
KalVista Pharmaceuticals was a new Legato Capital Management position in Q1 2026.
KalVista Pharmaceuticals made up 0.03% of Legato Capital Management's portfolio in Q1 2026, its #619 holding.
Legato Capital Management first reported a position in KalVista Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.